KV To Pay $28M Over Ethex Drug Safety Charges
KV Pharmaceutical Co. has agreed to pay $27.6 million to resolve U.S. Department of Justice charges that its generic pharmaceutical marketing and distribution subsidiary Ethex Corp. failed to notify regulators of...To view the full article, register now.
Already a subscriber? Click here to view full article